We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Breast Cancer Treatment – Prof. Andrew Tutt on the OlympiA Trial

Video  
Published: June 14, 2021 
| Taken from The Institute of Cancer Research, YouTube
The results of the OlympiA clinical trial, involving ICR researchers, shows giving the drug olaparib for one year to breast cancer patients with inherited BRCA mutations, after they have completed initial treatment, reduced the chance of their breast cancer returning.

Professor Andrew Tutt, Head of Breast Cancer Research at the ICR, explains more.

Related Topic Pages
Anticancer Therapies
Advertisement
Chosen for You
A vibrant 3D illustration of a protein molecule with intertwined structures in green, orange, and purple against a dark background.
Industry Insight

Advancing Protein Prototyping Through Rapid and Efficient Systems

A snippet of cancer metabolism and genetics infographic on a dark purple background.
Infographic

Mapping Cancer’s Blueprint: Genetics, Metabolism and Targeted Therapies
Cover page of a Sartorius publication featuring a vibrant illustration of cells encapsulated in spheres against a dark background.
eBook

Advancing Single-Cell Research With Automation
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter